Updated Brazilian guidelines for the management of immune-related adverse events associated with checkpoint inhibitors - edition 2.0

Immunotherapy (IT) in the form of monoclonal antibodies targeting coreceptors involved in the modulation of the immune synapse represents a standard of care for patients with distinct malignancies. Over the past years, evidences supporting the clinical use of IT both in monotherapy, as well as in co...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Rodrigo Ramella Munhoz, Clarissa Maria de Cerqueira Mathias, Guilherme Harada, Aknar Calabrich, Alberto Julius Wainstein, Andréia Cristina de Melo, Antonio Carlos Buzaid, Artur Katz, Carlos Gil Ferreira, Carlos Henrique dos Anjos, Clarissa Baldotto, Elimar Elias Gomes, Fernando Moura, Gilberto de Castro, Guilherme Nader Marta, Gustavo dos Santos Fernandes, Luiza Dib Batista Bugiato Faria, Mariana Laloni, Paulo Marcelo Gehm Hoff, Romualdo Barroso-Sousa, Sergio Jobim de Azevedo, Vladmir Cláudio Cordeiro de Lima, William Nassib William
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Thieme Revinter Publicações Ltda. 2022-10-01
Colecção:	Brazilian Journal of Oncology
Assuntos:	immunotherapy practice guideline adverse effects immune-checkpoint inhibitors
Acesso em linha:	https://www.brazilianjournalofoncology.com.br/details/197/en-US/updated-brazilian-guidelines-for-the-management-of-immune-related-adverse-events-associated-with-checkpoint-inhibitors---edition-2-0
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!